Berger Franklin M
SEC-identified person · CIK 1273885 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Atea Pharmaceuticals, Inc. AVIR | Director | filed 2020 - 2026 |
| Kezar Life Sciences, Inc. KZR | Director | filed 2018 - 2026 |
| Essa Pharma Inc. EPIX | Director | filed 2020 - 2025 |
| Rain Therapeutics Inc. RAIN | Director | filed 2021 - 2024 |
| Atreca, Inc. BCEL | Director | filed 2019 - 2023 |
| Five Prime Therapeutics, INC. FPRX | Director | filed 2013 - 2021 |
| Yumanity Therapeutics, INC. YMTX | Director | filed 2016 - 2020 |
| Tocagen Inc TOCA | Director | filed 2017 - 2019 |
| Immune Design Corp. IMDZ | Director | filed 2014 - 2019 |
| Seagen Inc. SGEN | Director | filed 2006 - 2014 |
| Asterias Biotherapeutics, Inc. ASTY | Director | filed 2013 - 2013 |
| Lineage Cell Therapeutics, Inc. LCTX | Director | filed 2013 - 2013 |
| Emisphere Technologies INC EMIS | Director | filed 2009 - 2009 |
| Diadexus, Inc. vxgn | Director · Director | filed 2007 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.